Header Logo

Connection

Kathleen Moore to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Cost-Benefit Analysis.
Kathleen Moore
Connection Strength
0.175
Cost-Benefit Analysis
  1. Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States. Gynecol Oncol. 2020 11; 159(2):491-497.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.